An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis

Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen

NCT00408668 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Experimental Vaccine for Malaria in Adults in Mali

NCT00343005 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909

NCT01351948 ·Status: COMPLETED ·Phase: PHASE1

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria

NCT07235020 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya

NCT00666380 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Effectiveness of a New Malaria Vaccine Candidate by Infecting Vaccinated Volunteers With Malaria Parasites

NCT00890760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy of Candidate Malaria Vaccines in Senegalese Adults

NCT01658696 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine

NCT07009847 ·Status: RECRUITING

Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAP

NCT01142765 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali

NCT06080243 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Vivax Malaria Human Infection Studies in Thailand

NCT04083508 ·Status: RECRUITING ·Phase: NA

A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S

NCT02252640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients

NCT05105035 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults

NCT05252845 ·Status: COMPLETED ·Phase: PHASE2

Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires

NCT01214876 ·Status: COMPLETED

Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania

NCT00513669 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2

NCT03203421 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

NCT00121862 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults

NCT07257965 ·Status: RECRUITING ·Phase: NA

Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP

NCT01364883 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAP

NCT03707353 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant

NCT02925403 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess Safety, Immunogenicity and Parasite Growth Inhibition of an Asexual Blood Stage Vaccine for P. Falciparum Malaria

NCT00984763 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis

NCT00340691 ·Status: COMPLETED ·Phase: PHASE2

A Study of AdCh63 AMA1 Alone and With MVA AMA1

NCT01095055 ·Status: COMPLETED ·Phase: PHASE1